Paul Kellam
Overview
Explore the profile of Paul Kellam including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
191
Citations
9461
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Miranda M, Kepl E, Navarro M, Chen C, Johnson M, Sprouse K, et al.
NPJ Vaccines
. 2024 Oct;
9(1):184.
PMID: 39379400
We previously described a two-component protein nanoparticle vaccine platform that displays 60 copies of the SARS-CoV-2 spike protein RBD (RBD-NP). The vaccine, when adjuvanted with AS03, was shown to elicit...
2.
Murugaiah V, Murugaiah V, Watson S, Watson S, Cunliffe R, Cunliffe R, et al.
J Infect Dis
. 2024 Sep;
231(2):e299-e307.
PMID: 39317662
The development of a universal influenza vaccine likely requires an understanding of previous exposure to influenza virus (through vaccination or infection) and how that shapes the antibody repertoire to vaccination,...
3.
Baker S, Krishna A, Higham S, Naydenova P, OLeary S, Scott J, et al.
Nat Commun
. 2024 Sep;
15(1):7979.
PMID: 39266557
The use of monoclonal antibodies for the control of drug resistant nosocomial bacteria may alleviate a reliance on broad spectrum antimicrobials for treatment of infection. We identify monoclonal antibodies that...
4.
Thai E, Murugan R, Binter S, Aschner C, Prieto K, Kassardjian A, et al.
Cell Rep
. 2023 Nov;
42(11):113330.
PMID: 38007690
IGHV3-33-encoded antibodies are prevalent in the human humoral response against the Plasmodium falciparum circumsporozoite protein (PfCSP). Among VH3-33 antibodies, cross-reactivity between PfCSP major repeat (NANP), minor (NVDP), and junctional (NPDP)...
5.
Kugathasan R, Sukhova K, Moshe M, Kellam P, Barclay W
PLoS Pathog
. 2023 Aug;
19(8):e1011545.
PMID: 37535672
New variants of SARS-CoV-2 are continually emerging with mutations in spike associated with increased transmissibility and immune escape. Phenotypic maps can inform the prediction of concerning mutations from genomic surveillance,...
6.
Ludwig J, Scally S, Costa G, Hoffmann S, Murugan R, Lossin J, et al.
NPJ Vaccines
. 2023 Jun;
8(1):86.
PMID: 37277334
No abstract available.
7.
Makori T, Bargul J, Lambisia A, Mwanga M, Murunga N, de Laurent Z, et al.
Virus Evol
. 2023 May;
9(1):vead025.
PMID: 37207000
The introduction of rotavirus vaccines into the national immunization programme in many countries has led to a decline in childhood diarrhoea disease burden. Coincidentally, the incidence of some rotavirus group...
8.
Ludwig J, Scally S, Costa G, Hoffmann S, Murugan R, Lossin J, et al.
NPJ Vaccines
. 2023 Apr;
8(1):52.
PMID: 37029167
The development of an effective and durable vaccine remains a central goal in the fight against malaria. Circumsporozoite protein (CSP) is the major surface protein of sporozoites and the target...
9.
Richardson E, Binter S, Kosmac M, Ghraichy M, von Niederhausern V, Kovaltsuk A, et al.
Elife
. 2023 Mar;
12.
PMID: 36971345
Immunoglobulin loci-transgenic animals are widely used in antibody discovery and increasingly in vaccine response modelling. In this study, we phenotypically characterised B-cell populations from the Intelliselect Transgenic mouse (Kymouse) demonstrating...
10.
Higham S, Baker S, Flight K, Krishna A, Kellam P, Reece S, et al.
J Infect
. 2023 Mar;
86(6):563-573.
PMID: 36858180
Objectives: The multidrug-resistant bacteria Acinetobacter baumannii is a major cause of hospital-associated infection; a vaccine could significantly reduce this burden. The aim was to develop a clinically relevant model of...